Weight loss significant among patients with idiopathic pulmonary fibrosis treated with nintedanib : vimarsana.com

Japan: A recent study published in Pulmonary Pharmacology & Therapeutics has shown weight loss to be a critical issue for managing nintedanib-treated patients with idiopathic pulmonary fibrosis...

Related Keywords

Japan , Kobe , Hyogo , Hiromi Tomioka , Kobe City Medical Center West Hospital , , Common Terminology Criteria , Adverse Events , Pulmonary Pharmacology Amp Therapeutics , Nintedanib , Idiopathic Pulmonary Fibrosis , Eight Loss , Neumonia , Interstitial Lung Disease , Urvival , Weight Reduction ,